Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Secondary cancers
Closed
Phase 3
This trial is looking at trastuzumab deruxtecan (T-DXd) with or without pertuzumab for breast cancer that has spread to another part of the body.
It is for people who have not had any treatment for their . Their cancer needs to have the .
Recruitment start: 4 October 2021
Recruitment end: 29 September 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Caroline Michie
AstraZeneca
Last reviewed: 29 Sept 2023
CRUK internal database number: 18321
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
